TY - JOUR T1 - NPS MedicineWise evaluation finds changes in general practitioners’ prescribing of proton pump inhibitors following education programmes JF - BMJ Quality & Safety JO - BMJ Qual Saf SP - 68 LP - 69 DO - 10.1136/bmjqs-2020-012111 VL - 30 IS - 1 AU - Suzanne G Blogg Y1 - 2021/01/01 UR - http://qualitysafety.bmj.com/content/30/1/68.abstract N2 - I write in response to the article published in your journal “Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia” (Bruno C et al, BMJ Qual Saf 2019). I am writing as NPS MedicineWise evaluation found a significant impact on general practitioner (GP) prescribing of proton pump inhibitors (PPIs) following their educational programmes in 2009 and 2015. I acknowledge that the article is well written, the methods are well described and the approach includes a number of sensitivity analyses. However, I would like to highlight some key points on the analysis methods used that differ from the approach taken by NPS MedicineWise and about which I have some concerns.The 2015 NPS MedicineWise educational programme on PPIs was part of a larger educational strategy over a decade to support best-practice prescribing of PPIs by GPs and included Pharmaceutical Benefits Scheme (PBS) feedback to GPs in Australia. This consists of a letter that includes information of the individual GP’s prescribing of PPIs compared with … ER -